| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/25/2001 | WO2001000867A3 Method for typing a photoperiodic animal for a seasonal physiological function by gene typing |
| 05/25/2001 | WO2000079273A3 Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| 05/25/2001 | WO2000078330A3 Adenosine diphosphatase and activators thereof and their medical uses |
| 05/25/2001 | WO2000075278A3 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 05/25/2001 | WO2000075190A3 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 05/25/2001 | WO2000073338A8 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 05/25/2001 | WO2000070024A3 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 05/25/2001 | WO2000061814A8 Detection of chromosome copy number changes to distinguish melanocytic nevi from malignant melanoma |
| 05/25/2001 | WO2000047750B1 Metalloproteases of the neprilysin family |
| 05/25/2001 | WO2000010588A3 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 05/25/2001 | WO1999063087A8 G-protein coupled receptor, named 2871 receptor |
| 05/25/2001 | CA2794123A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2738796A1 Biglycan and uses thereof in stabilizing dystrophin associated protein complexes |
| 05/25/2001 | CA2732120A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 05/25/2001 | CA2685349A1 Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| 05/25/2001 | CA2427106A1 Method and apparatus for prokaryotic and eukaryotic cell quantitation |
| 05/25/2001 | CA2396428A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/25/2001 | CA2392218A1 Simultaneous detection of hbv, hcv and hiv in plasma samples using a multiplex capture assay |
| 05/25/2001 | CA2392103A1 Human fgf-21 gene and gene expression products |
| 05/25/2001 | CA2392090A1 G-protein coupled receptor |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2392051A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 05/25/2001 | CA2391998A1 Method for assessing genotoxicity of a compound |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391743A1 Apparatus and method for assaying coagulation in fluid samples |
| 05/25/2001 | CA2391669A1 Mammalian genes: related reagents and methods |
| 05/25/2001 | CA2391593A1 Selectable cell surface marker genes |
| 05/25/2001 | CA2391571A1 Method for rapid and accurate identification of microorganisms |
| 05/25/2001 | CA2391558A1 Immunological detection of rna:dna hybrids on microarrays |
| 05/25/2001 | CA2391531A1 Placental human neurokinin b precursor |
| 05/25/2001 | CA2391504A1 New olfactory receptor polypeptides and dna sequences thereof |
| 05/25/2001 | CA2391423A1 Polymeric transition metal complexes and uses thereof |
| 05/25/2001 | CA2391403A1 Novel protein and dna thereof |
| 05/25/2001 | CA2391212A1 Methods and compositions for identifying disease markers |
| 05/25/2001 | CA2391084A1 High order nucleic acid based structures |
| 05/25/2001 | CA2390607A1 Materials and methods for detection and treatment of breast cancer |
| 05/25/2001 | CA2390548A1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 05/25/2001 | CA2390051A1 Thymidylate synthase polymorphism for predicting chemotherapeutic response |
| 05/25/2001 | CA2390031A1 Double-stranded rna receptor (dsrna-r) and methods relating thereto |
| 05/25/2001 | CA2389662A1 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/25/2001 | CA2389569A1 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | CA2389289A1 Mammalian toxicological response markers |
| 05/25/2001 | CA2388922A1 23 human secreted proteins |
| 05/25/2001 | CA2388904A1 Hydrolytic enzyme substrates and assay method |
| 05/25/2001 | CA2388777A1 18 human secreted proteins |
| 05/25/2001 | CA2388703A1 Long oligonucleotide arrays |
| 05/25/2001 | CA2388563A1 Diagnosis kit, method and microarray for determining human detoxification capacity |
| 05/25/2001 | CA2388561A1 Method for the controlled implementation of complex pcr amplifications |
| 05/25/2001 | CA2385090A1 Cloning and characterization of the cap gene promoter |
| 05/25/2001 | CA2324496A1 New nucleotide sequences coding for the genes succ and sucd |
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/23/2001 | EP1102067A1 Method for assaying anti-gad antibody and kit |
| 05/23/2001 | EP1101824A2 Detection of sequence variation of nucleic acid by shifted termination analysis |
| 05/23/2001 | EP1101821A1 Novel protein and its dna |
| 05/23/2001 | EP1101820A1 Pentraxin I and Pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 05/23/2001 | EP1101532A2 Dispenser for producing DNA microarray |
| 05/23/2001 | EP1101499A2 Diagnostic agents for pancreatic exocrine function |
| 05/23/2001 | EP1101117A1 A rapid method to detect duplex formation in sequencing by hybridization methods, a method for constructing containment structures for reagent interaction |
| 05/23/2001 | EP1101115A1 Method for preparing water-soluble cross-linked conjugates |
| 05/23/2001 | EP1101113A1 Cell-signaling assays |
| 05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
| 05/23/2001 | EP1101106A1 Device and method for cell motility assay |
| 05/23/2001 | EP1101104A1 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 05/23/2001 | EP1101102A2 Micro-system with multiple points for chemical or biological analysis |
| 05/23/2001 | EP1100973A1 Oligomers which inhibit expression of collagen genes |
| 05/23/2001 | EP1100972A1 Reversible inhibiting probes |
| 05/23/2001 | EP1100971A1 Wavelength-shifting probes and primers |
| 05/23/2001 | EP1100970A2 Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals |
| 05/23/2001 | EP1100969A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 05/23/2001 | EP1100968A1 Genotyping human udp-glucuronosyltransferase 2b4 (ugt2b4), 2b7 (ugt2b7) and 2b15 (ugt2b15) genes |
| 05/23/2001 | EP1100967A2 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 05/23/2001 | EP1100966A1 In situ method of analyzing cells |
| 05/23/2001 | EP1100965A1 Method of and composite for fluorescent in situ hybridization |
| 05/23/2001 | EP1100964A1 Gene sequence variances with utility in determining the treatment of disease |
| 05/23/2001 | EP1100963A2 Human ccr-2 gene polymorphisms |
| 05/23/2001 | EP1100962A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100961A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 05/23/2001 | EP1100960A1 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
| 05/23/2001 | EP1100959A2 Method and kit for detecting resistance to antiviral drugs |
| 05/23/2001 | EP1100958A2 Nucleic acid molecules with specific identification of native prp?sc , their production and the use thereof |
| 05/23/2001 | EP1100957A1 Method for identification and isolation of hematopoietic progenitor cells |
| 05/23/2001 | EP1100956A2 Process for identification of substances modulating urei dependent mechanisms of helicobacter pylori metabolism |
| 05/23/2001 | EP1100955A2 Agent and method for modulation of cell migration |
| 05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
| 05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
| 05/23/2001 | EP1100933A1 New caspase homologue |
| 05/23/2001 | EP1100929A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 05/23/2001 | EP1100923A2 Thermostable in vitro complex with polymerase activity |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100912A1 Method for screening of modulators of calcineurin activity |
| 05/23/2001 | EP1100911A1 Eukaryotic cell-based gene interaction cloning |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |